Quick Answer
Oncology Institute, Inc. reported Total Assets of $164.66 million for the year ending 2025.
- Oncology Institute, Inc. showed a decrease of -4.7% in Total Assets from 2024 to 2025.
- This data is from Oncology Institute, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $231.84 million | Q2 2020: $231.47 million | Q3 2020: $231.40 million | Q1 2021: $231.04 million | Q2 2021: $230.75 million | Q3 2021: $230.30 million | Q1 2022: $206.51 million | Q2 2022: $189.74 million | Q3 2022: $283.80 million | Q1 2023: $234.63 million | Q2 2023: $229.96 million | Q3 2023: $218.35 million | Q1 2024: $204.53 million | Q2 2024: $179.60 million | Q3 2024: $179.18 million | Q1 2025: $164.00 million | Q2 2025: $159.80 million | Q3 2025: $163.62 million.
- Over the full 7 years of available data (2019 to 2025), Oncology Institute, Inc.'s Total Assets has grown by 329,212.0%.
- Historical annual values: Fiscal year 2025: $164.66 million | Fiscal year 2024: $172.72 million | Fiscal year 2023: $209.24 million | Fiscal year 2022: $261.67 million | Fiscal year 2021: $203.44 million | Fiscal year 2020: $65.69 million | Fiscal year 2019: $50.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: